Researchers with the UCLA Jonsson Comprehensive Cancer Center have discovered when adding ribociclib to hormone therapy has unexpected benefits for breast cancer patients in a recent study shared Friday. When ribociclib is added to hormone therapy, there are significant invasive disease-free survival benefits in patients with early hormone-receptor positive/HER2 negative breast cancer, the study shows. […]